I am Minami of Resona Holdings. Thank you very much for joining us today for the presentation of our new medium-term management plan despite your busy schedules. This is our first attempt, but I would ...
Amneal Pharmaceuticals, Inc. rated a Buy: strong revenue growth, diverse pipeline, and undervaluation vs peers—Click for AMRX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results